Patients with sickle cell disease may soon have two new treatments to try.
retrieved 30 October 2023 from https://medicalxpress.com/news/2023-10-fda-advisors-gene-therapy-sickle.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves mirikizumab for induction and maintenance therapyThe FDA has approved mirikizumab as a treatment for induction and maintenance therapy in certain patients.
Weiterlesen »
FDA warns eyedrops from major brands may cause infectionFederal regulators are warning consumers to stop using eyedrops and gels from several major brands after finding unsanitary conditions in a manufacturing plant.
Weiterlesen »
Hospital Gene Therapy Aims to Free Patients from Chronic PainA new gene therapy treatment being developed at a hospital aims to provide long-term relief from chronic pain for patients. The therapy targets specific genes involved in pain signaling and aims to modify them to reduce pain sensitivity. Early trials have shown promising results, with patients experiencing significant pain reduction. If successful, this gene therapy could revolutionize the treatment of chronic pain and provide a much-needed alternative to opioids.
Weiterlesen »
New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patientsCanadian researchers develop a cell-free DNA-based multimodal assay for early cancer detection in patients with Li-Fraumeni Syndrome, a high-cancer-risk condition. The assay outperforms conventional methods, promising more sensitive and less invasive cancer surveillance.
Weiterlesen »
The Worst Thing for Diabetes PatientsNeglecting medication or insulin regimen can lead to dangerous fluctuations in blood sugar levels, resulting in short-term and long-term complications.
Weiterlesen »